Literature DB >> 32732330

Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance.

Charles D Bengtson1,2, Michael D Kim1,2, Abeer Anabtawi3, Jianghua He4, John S Dennis1, Sara Miller1, Makoto Yoshida1, Nathalie Baumlin1, Matthias Salathe5.   

Abstract

Large-conductance, Ca2+-activated, voltage-dependent K+ (BK) channel function is critical for adequate airway hydration and mucociliary function. In airway epithelia, BK function is regulated by its γ-subunit, leucine-rich repeat-containing protein 26 (LRRC26). Since patients with cystic fibrosis (CF)-related diabetes mellitus (CFRD) have worse lung function outcomes, this study determined the effects of hyperglycaemia on BK function in CF bronchial epithelial (CFBE) cells in vitro and evaluated the correlation between glycaemic excursions and mRNA expression of LRRC26 in the upper airways of CF and CFRD patients.CFBE cells were redifferentiated at the air-liquid interface (ALI) in media containing either 5.5 mM or 12.5 mM glucose. BK activity was measured in an Ussing chamber. Airway surface liquid (ASL) volume was estimated by meniscus scanning and inflammatory marker expression was measured by quantitative real-time PCR and enzyme-linked immunosorbent assay (ELISA). CF patients were assessed by 7 days of continuous glucose monitoring (CGM). LRRC26 mRNA expression was measured by quantitative real-time PCR from nasal cells obtained at the end of glucose monitoring.BK currents were significantly decreased in CFBE cells cultured under high glucose. These cells revealed significantly lower ASL volumes and increased inflammation, including the receptor for advanced glycation endproducts (RAGE), compared to cells cultured in normal glucose. In vivo, nasal cell expression of LRRC26 mRNA was inversely correlated with hyperglycaemic excursions, consistent with the in vitro results.Our findings demonstrate that hyperglycaemia induces inflammation and impairs BK channel function in CFBE cells in vitro These data suggest that declining lung function in CFRD patients may be related to BK channel dysfunction.
Copyright ©ERS 2021.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32732330      PMCID: PMC8884026          DOI: 10.1183/13993003.00509-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  40 in total

1.  Functional apical large conductance, Ca2+-activated, and voltage-dependent K+ channels are required for maintenance of airway surface liquid volume.

Authors:  Dahis Manzanares; Carlos Gonzalez; Pedro Ivonnet; Ren-Shiang Chen; Monica Valencia-Gattas; Gregory E Conner; H Peter Larsson; Matthias Salathe
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

2.  Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.

Authors:  Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

3.  Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.

Authors:  A Leclercq; B Gauthier; V Rosner; L Weiss; F Moreau; A A Constantinescu; R Kessler; L Kessler
Journal:  J Cyst Fibros       Date:  2013-12-17       Impact factor: 5.482

4.  Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.

Authors:  Melena D Bellin; Theresa Laguna; Janice Leschyshyn; Warren Regelmann; Jordan Dunitz; JoAnne Billings; Antoinette Moran
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

5.  LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium.

Authors:  Jiusheng Yan; Richard W Aldrich
Journal:  Nature       Date:  2010-07-07       Impact factor: 49.962

6.  Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.

Authors:  Alicia K Olivier; Yaling Yi; Xingshen Sun; Hongshu Sui; Bo Liang; Shanming Hu; Weiliang Xie; John T Fisher; Nicholas W Keiser; Diana Lei; Weihong Zhou; Ziying Yan; Guiying Li; Turan I A Evans; David K Meyerholz; Kai Wang; Zoe A Stewart; Andrew W Norris; John F Engelhardt
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

7.  Human nasal and tracheo-bronchial respiratory epithelial cell culture.

Authors:  M Leslie Fulcher; Scott H Randell
Journal:  Methods Mol Biol       Date:  2013

8.  Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.

Authors:  William R Hunt; Beth R Helfman; Nael A McCarty; Jason M Hansen
Journal:  J Cyst Fibros       Date:  2016-01-23       Impact factor: 5.482

Review 9.  Receptor for advanced glycation end products and its involvement in inflammatory diseases.

Authors:  Yaw Kuang Chuah; Rusliza Basir; Herni Talib; Tung Hing Tie; Norshariza Nordin
Journal:  Int J Inflam       Date:  2013-09-11

10.  IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis.

Authors:  Gang Chen; Ling Sun; Takafumi Kato; Kenichi Okuda; Mary B Martino; Aiman Abzhanova; Jennifer M Lin; Rodney C Gilmore; Bethany D Batson; Yvonne K O'Neal; Allison S Volmer; Hong Dang; Yangmei Deng; Scott H Randell; Brian Button; Alessandra Livraghi-Butrico; Mehmet Kesimer; Carla Mp Ribeiro; Wanda K O'Neal; Richard C Boucher
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 19.456

View more
  5 in total

1.  A medium composition containing normal resting glucose that supports differentiation of primary human airway cells.

Authors:  Rachel Morgan; Candela Manfredi; Kristen F Easley; Lionel D Watkins; William R Hunt; Steven L Goudy; Eric J Sorscher; Michael Koval; Samuel A Molina
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

Review 2.  Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation.

Authors:  Divya Guntur; Horst Olschewski; Péter Enyedi; Réka Csáki; Andrea Olschewski; Chandran Nagaraj
Journal:  Biomolecules       Date:  2021-11-03

3.  Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies.

Authors:  Michael D Kim; Charles D Bengtson; Makoto Yoshida; Asef J Niloy; John S Dennis; Nathalie Baumlin; Matthias Salathe
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

4.  The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function.

Authors:  Charles Bengtson; Neerupma Silswal; Nathalie Baumlin; Makoto Yoshida; John Dennis; Sireesha Yerrathota; Michael Kim; Matthias Salathe
Journal:  Int J Mol Sci       Date:  2022-09-19       Impact factor: 6.208

5.  Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction.

Authors:  Michael D Kim; Samuel Chung; John S Dennis; Makoto Yoshida; Carolina Aguiar; Sheyla P Aller; Eliana S Mendes; Andreas Schmid; Juan Sabater; Nathalie Baumlin; Matthias Salathe
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.